Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 May 2004, Vol. 103, No. 10, pp. 3777-3782.
Prepublished online as a Blood First Edition Paper on January 22, 2004February 5, 2004; DOI 10.1182/blood-2003-11-4051.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2003-11-4051v1
2003-11-4051v2
103/10/3777    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Espirito Santo, S. M
Right arrow Articles by van Vlijmen, B. J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Espirito Santo, S. M
Right arrow Articles by van Vlijmen, B. J
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted December 1, 2003
Accepted January 12, 2004

Hepatic Low-Density Lipoprotein Receptor-Related Protein Deficiency in Mice Increases Atherosclerosis Independent of Plasma Cholesterol

Sonia M Espirito Santo, Nuno M Pires, Lianne S Boesten, Gery Gerritsen, Niels Bovenschen, Ko Willems van Dijk, J W Jukema, Hans M Princen, Andre Bensadoun, Wei-Ping Li, Joachim Herz, Louis M Havekes, and Bart J van Vlijmen*

Biomedical Research, TNO-Prevention and Health, Leiden, The Netherlands; Cardiology, Leiden University Medical Center, Leiden, The Netherlands
Human Genetics, Leiden University Medical Center, Leiden, The Netherlands
Biomedical Research, TNO-Prevention and Health, Leiden, The Netherlands; Plasma proteins, Sanquin Research at CLB, Amsterdam, The Netherlands
Human Genetics, Leiden University Medical Center, Leiden, The Netherlands; General Internal Medicine, Leiden University Medical Center, Leiden, The Netherlands
Cardiology, Leiden University Medical Center, Leiden, The Netherlands
Biomedical Research, TNO-Prevention and Health, Leiden, The Netherlands
Division of Nutritional Sciences, Cornell University, Ithaca, NY, USA
Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX, USA
Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, TX, USA
Biomedical Research, TNO-Prevention and Health, Leiden, The Netherlands; Cardiology, Leiden University Medical Center, Leiden, The Netherlands; Plasma proteins, Sanquin Research at CLB, Amsterdam, The Netherlands

* Corresponding author; email: bjm.vanvlijmen{at}pg.tno.nl.

The low-density lipoprotein (LDL) receptor-related protein (LRP) has a well-established role in the hepatic removal of atherogenic apolipoprotein (APO) E-rich remnant lipoproteins from plasma. In addition, LRP recognizes multiple distinct pro- and anti-atherogenic ligands in vitro. Here, we investigated the role of hepatic LRP in atherogenesis independent of its role in removal of APOE-rich remnant lipoproteins. Mice that allow inducible inactivation of hepatic LRP were combined with LDL receptor and APOE double deficient mice (MX1Cre+LRPflox/floxLDLR-/-APOE-/-). On a LDLR-/-APOE-/- background, hepatic LRP deficiency resulted in decreased plasma cholesterol and triglycerides (cholesterol: 17.1±5.2 vs. 23.4±6.3 mM, P=0.025; triglycerides: 1.1±0.5 vs. 2.2±0.8 mM, P=0.002; for MX1Cre+LRPflox/floxLDLR-/-APOE-/- and control LRPflox/floxLDLR-/-APOE-/- mice, respectively). Lower plasma cholesterol in MX1Cre+LRPflox/floxLDLR-/-APOE-/- mice coincided with increased plasma lipoprotein lipase (71.2±7.5 vs. 19.1±2.4 ng/ml, P=0.002), coagulation factor VIII (4.4±1.1 vs. 1.9±0.5 U/mL, P=0.001), von Willebrand factor (2.8±0.6 vs. 1.4±0.3 U/mL, P=0.001), and tissue-type plasminogen activator (1.7±0.7 vs. 0.9±0.5 ng/ml, P=0.008) as compared to controls. Strikingly, MX1Cre+LRPflox/floxLDLR-/-APOE-/- mice showed a 2-fold higher atherosclerotic lesion area as compared to controls (408.5±115.1 vs. 219.1±86.0 103µm2, P=0.003). Our data indicate that hepatic LRP plays a clear protective role in atherogenesis independent of plasma cholesterol, possibly due to maintaining low levels of its pro-atherogenic ligands.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. L.S.M. Gordts, S. Reekmans, A. Lauwers, A. Van Dongen, L. Verbeek, and A. J.M. Roebroek
Inactivation of the LRP1 Intracellular NPxYxxL Motif in LDLR-Deficient Mice Enhances Postprandial Dyslipidemia and Atherosclerosis
Arterioscler Thromb Vasc Biol, September 1, 2009; 29(9): 1258 - 1264.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
A. P. Lillis, L. B. Van Duyn, J. E. Murphy-Ullrich, and D. K. Strickland
LDL Receptor-Related Protein 1: Unique Tissue-Specific Functions Revealed by Selective Gene Knockout Studies
Physiol Rev, July 1, 2008; 88(3): 887 - 918.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C. D. Overton, P. G. Yancey, A. S. Major, M. F. Linton, and S. Fazio
Deletion of Macrophage LDL Receptor-Related Protein Increases Atherogenesis in the Mouse
Circ. Res., March 16, 2007; 100(5): 670 - 677.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. Hu, L.S.M. Boesten, P. May, J. Herz, N. Bovenschen, M.V. Huisman, J.F.P. Berbee, L.M. Havekes, B.J.M. van Vlijmen, and J.T. Tamsma
Macrophage Low-Density Lipoprotein Receptor-Related Protein Deficiency Enhances Atherosclerosis in ApoE/LDLR Double Knockout Mice
Arterioscler Thromb Vasc Biol, December 1, 2006; 26(12): 2710 - 2715.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
K. E. Kypreos and V. I. Zannis
LDL receptor deficiency or apoE mutations prevent remnant clearance and induce hypertriglyceridemia in mice
J. Lipid Res., March 1, 2006; 47(3): 521 - 529.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
N. Bovenschen, K. Mertens, L. Hu, L. M. Havekes, and B. J. M. van Vlijmen
LDL receptor cooperates with LDL receptor-related protein in regulating plasma levels of coagulation factor VIII in vivo
Blood, August 1, 2005; 106(3): 906 - 912.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
S. M. S. E. Santo, P. C. N. Rensen, J. R. Goudriaan, A. Bensadoun, N. Bovenschen, P. J. Voshol, L. M. Havekes, and B. J. M. van Vlijmen
Triglyceride-rich lipoprotein metabolism in unique VLDL receptor, LDL receptor, and LRP triple-deficient mice
J. Lipid Res., June 1, 2005; 46(6): 1097 - 1102.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2004 by American Society of Hematology         Online ISSN: 1528-0020